To investigate the effect of aromatherapy on reperfusion injury protection and long-term prognosis after STEMI intervention: a prospective, randomized controlled study

Phase 4

Recruiting

• Conditions: Acute myocardial infarction

• Registration Number: ITMCTR2000003213
• Lead Sponsor: Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of TCM

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 20 February 2023

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

1. Voluntarily participate in the study and sign the informed consent;
2. Patients with acute ST elevation myocardial infarction;
3. Direct PCI indications;
4. Aged 20 to 80 years.

Exclusion Criteria

1. Chest pain symptoms > for 12 hours;
2. Severe hypotension or cardiogenic shock that cannot be corrected by optimized medication;
3. Successful thrombolysis ;
4. Platelet (PLT) < 100,000mm3 or male hemoglobin (Hb) < 120g/L, female < 110g/L; Creatinine > 110 umol/L; Uric acid > 0.42mol/L; Heart rate < 50 beats/min; BMI < 18.5kg/m2 or >= 24kg/m2; Male weight < 50Kg; Female weight < 40Kg;
5. History of other myocardial infarction in the past 5 weeks;
6. The condition was unable to complete PCI;
7. Pregnant and nursing women;
8. Participated in other clinical trials within the past 1 month;
9. Not suitable for participants.

Study & Design

• Study Type: Interventional study
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
CTFC;

Secondary Outcome Measures

Name	Time	Method
ST-segment resolution;MACE;CK, CK-M, cTnI;